NCI coronavirus
NCI COVID-19 Cancer Trials Update
March 16, 2020
The National Cancer Institute has issued an interim guidance for all NCTN and NCORP cancer trials given the impact the COVID-19 outbreak is having on hospitals.
You can read the guidance here.
The NCI also issued another guidance for patients on Division of Cancer Prevention trials. You can read that document here.
These documents will be continually updated by the CIRB as more information becomes available. Keep checking the CIRB webpage for announcements and for their FAQ about treating patients on NCI cancer trials in the context of the coronovirus pandemic.
Other Recent Stories
Apr 25, 2025
Standing sessions and special events at spring group meeting
Apr 18, 2025
Here are just some of the great committee session keynotes we'll hear in San Francisco
Apr 16, 2025
Landmark trial expands genomic screening options for enrolling patients